Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Alector (ALEC) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Alector (ALEC) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.

Alector (NASDAQ:ALEC) Shares Down 10.2%

08:54am, Tuesday, 25'th Feb 2020
Alector Inc (NASDAQ:ALEC)’s stock price was down 10.2% during trading on Monday . The stock traded as low as $26.53 and last traded at $27.35, approximately 988,012 shares traded hands during tradin
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that Arnon.
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering...
Alector (NASDAQ:ALEC) and Coherus Biosciences (NASDAQ:CHRS) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst reco
Cannell Peter B & Co. Inc. grew its holdings in Alector Inc (NASDAQ:ALEC) by 24.8% in the 4th quarter, Holdings Channel reports. The fund owned 116,250 shares of the company’s stock after purchasing
Stifel Nicolaus assumed coverage on shares of Alector (NASDAQ:ALEC) in a research report report published on Tuesday morning, BenzingaRatingsTable reports. The firm issued a buy rating on the stock. S
Oppenheimer & Co. Inc. raised its stake in Alector Inc (NASDAQ:ALEC) by 101.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.
Alector (NASDAQ:ALEC) initiated with Buy rating and $44 (52% upside) price target at Stifel.Aridis Pharmaceuticals (NASDAQ:ARDS) initiated with Buy rating and $18 (193% upside) price target at Roth Ca
Passage Bio has filed to raise $126 million in an IPO of its common stock. The firm is a pre-clinical biopharma working on monogenic treatments for central nerv
Alector Inc (NASDAQ:ALEC) VP Calvin Yu sold 63,541 shares of the business’s stock in a transaction on Tuesday, February 4th. The shares were sold at an average price of $30.04, for a total value of
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced gr
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE